In a Clinical Trial a new drug, treatment or procedure is tested in a group of volunteers. The most common drugs, diagnostic techniques and procedures in today's medical society, were at one time, revolutionary ideas that were tested, proven and improved by the four phases of the clinical trial system.
The heroes of this process are the volunteers. Volunteers, who are properly informed of any risks associated with trial participation, are not only helping to advance medical science but are also the earliest beneficiaries of the finest medical treatments in the world.
Please call Mary Ann DeMuro, ARNP, at (502) 852-5237 to participate in the study. Compensation will be provided for participation in the study.
- 381-07. Hypertension in Type 2 Diabetes. A randomized, double-blind, placebo-controlled, parallel-group study to determine whether, in patients with type 2 diabetes at high risk for cardiovascular and renal events, aliskiren, on top of conventional treatment, reduces cardiovascular and renal morbidity and mortality. Sponsor - Novartis Pharmaceuticals. Aliskiren is the first in a new class of orally active direct renin inhibitors that is FDA approved for the treatment of hypertension. The drug blocks the renin system at its point of activation by directly inhibiting plasma renin activity. Patients over age 35 years with type 2 diabetes who are treated with oral agents or insulin are eligible for the study. The purpose of the research is to determine whether adding aliskiren to conventional treatments delays the occurrence of cardiovascular or renal complications of diabetes.
- 07.0066. Male Hypogonadism. An Open Label Phase 3 Study of Fortigel Testosterone Gel 2% in Hypogonadal Males. Sponsor - Prostrakan Pharmaceuticals. Trial Closed.